Society guideline links: Management of Staphylococcus aureus infection

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately.

●(See "Society guideline links: Skin and soft tissue infections".)

●(See "Society guideline links: Bacterial meningitis in adults".)

●(See "Society guideline links: Osteomyelitis and prosthetic joint infection in adults".)

●(See "Society guideline links: Septic arthritis in adults".)

●(See "Society guideline links: Hospital-acquired pneumonia and ventilator-associated pneumonia in adults".)

●(See "Society guideline links: Community-acquired pneumonia in adults".)

●(See "Society guideline links: Infection control".)

●(See "Society guideline links: Venous access".)

Canada

●Choosing Wisely Canada: Don't prescribe aminoglycosides for synergy to patients with bacteremia or native valve infective endocarditis caused by Staphylococcus aureus (2021)

●Canadian Paediatric Society (CPS): Practice point for management of community-associated methicillin-resistant Staphylococcus aureus skin abscesses in children (2011, reaffirmed 2020)

United States

●American Academy of Pediatrics (AAP): Red Book – Staphylococcus aureus (2024)

●Society for Healthcare Epidemiology of America (SHEA), Infectious Diseases Society of America (IDSA), Association for Professionals in Infection Control and Epidemiology (APIC), American Hospital Association (AHA), and The Joint Commission: Practice recommendation on strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals, 2022 update (published 2023)

●American Society of Health-System Pharmacists (ASHP), IDSA, Pediatric Infectious Diseases Society (PIDS), and Society of Infectious Diseases Pharmacists (SIDP): Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections – A revised consensus guideline and review (2020)

●Centers for Disease Control and Prevention (CDC): Recommendations for prevention and control of infections in neonatal intensive care unit patients – Staphylococcus aureus (2020)

●SHEA: Neonatal intensive care unit (NICU) white paper series – Practical approaches to Staphylococcus aureus disease prevention (2020)

●IDSA: Clinical practice guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children (ARCHIVED; published 2011)

United Kingdom

●British Society for Antimicrobial Chemotherapy (BSAC) and British Infection Association (BIA): Treatment of methicillin-resistant Staphylococcus aureus (MRSA) – Updated guidelines from the UK (2021)

●Healthcare Infection Society (HIS) and Infection Prevention Society (IPS): Joint guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities (2021)